48951-3018 NDC - CAPSICUM CHAMOMILLA SPECIAL ORDER

Drug Information

  • Product NDC: 48951-3018
  • Proprietary Name: Capsicum Chamomilla Special Order
  • Non Proprietary Name: Capsicum Chamomilla Special Order
  • Active Ingredient(s): 12 [hp_X]/mL FERROSOFERRIC PHOSPHATE; 2 [hp_X]/mL LEVISTICUM OFFICINALE ROOT; 3 [hp_X]/mL MATRICARIA RECUTITA; 12 [hp_X]/mL MERCURIC IODIDE; 6 [hp_X]/mL PAPRIKA; 6 [hp_X]/mL PULSATILLA VULGARIS
  • Administration Route(s): ORAL
  • Dosage Form(s): LIQUID
  • Pharmacy Class(es): Allergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]; Increased Histamine Release [PE]; Non-Standardized Food Allergenic Extract [EPC]

Labeler Information

Field Name Field Value
Labeler Name: Uriel Pharmacy Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:9/1/2009

Package Information

No. Package Code Package Description Billing Unit
148951-3018-110 AMPULE in 1 BOX (48951-3018-1) / 1 mL in 1 AMPULE

NDC Record

Field Name Field Value Definition
PRODUCT NDC48951-3018The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGThis is the date that the labeler indicates was the start of its marketing of the drug product.
PROPRIETARY NAMECapsicum Chamomilla Special OrderProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
NON PROPRIETARY NAMECapsicum Chamomilla Special OrderThis corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
DOSAGE FORM NAMELIQUIDName of Company corresponding to the labeler code segment of the Product NDC.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE9/1/2009The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
LABELER NAMEUriel Pharmacy Inc. 
SUBSTANCE NAMEFERROSOFERRIC PHOSPHATE; LEVISTICUM OFFICINALE ROOT; MATRICARIA RECUTITA; MERCURIC IODIDE; PAPRIKA; PULSATILLA VULGARISAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH12; 2; 3; 12; 6; 6 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAllergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/6/2025